Edwards Lifesciences reports 8% Q1 2025 sales growth to $1.41B, driven by TAVR & TMTT. Discover regulatory catalysts & future growth insights.

For young Indians grappling with aortic valve disease, the Ross procedure offers a lifeline—one that restores vitality ...

Solo Pace announced today that it received FDA clearance for its SoloPace Control System for temporary pacing in TAVR ...

Solo Pace Incorporated, an emerging medical technology company, announced both FDA Clearance and First-In-Human use of their SoloPace Control System for temporary pacing in Transcatheter Aortic Valve ...

Investing.com - U.S. President Donald Trump's decision to delay most of his sweeping tariffs could help reduce the risk of the economy sliding into a period of elevated inflation and tepid growth ...

New York City's famed Garment District is bracing for impact as President Trump's barrage of tariffs begin to ripple through the apparel industry. For Lyn and Lisa Alessi, co-founders and co-CEOs ...

Transcatheter Aortic Valve Replacement Market outlook through 2035, highlighting key trends, growth drivers, challenges, and future opportunities ...

The RBI’s shift to an accommodative stance and continued liquidity measures signal a broader effort to mitigate the risks from external shocks and support domestic growth amid a changing global trade ...

Photo: Saul Loeb/AFP/Getty Images Federal Reserve officials highlighted the risks of longer-lasting inflationary pressures from tariffs when they agreed to hold interest rates steady at their ...

America must invest at least $15 billion over the next five years to support its domestic biotechnology sector if it doesn’t want to lose to China, warns a national security commission made up ...